![David Montecalvo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Montecalvo
Director/Board Member at
Olin Business School
Profile
David A. Montecalvo is SVP, Chief Operations & Supply Chain Officer at West Pharmaceutical Services, Inc. In the past he occupied the position of Vice President-Operations at Urologix, Inc. and Vice President-Contract Manufacturing Operations at Medtronic Plc and Vice President-Product Development & Operations at Medtronic CardioVascular (a subsidiary of Medtronic Plc). He received an MBA from St. Thomas University (Florida) and an undergraduate degree from Case Western Reserve University.
David Montecalvo active positions
| Companies | Position | Start |
|---|---|---|
Olin Business School
 Olin Business School Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | 2017-01-31 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Consultant / Advisor | 2022-09-30 |
Vance Street Management LLC
 Vance Street Management LLC Investment ManagersFinance Vance Street invests in middle market companies located in the United States or Canada with an enterprise values of USD 30 - 350 million and EBITDA of USD 3 - 30 million. The firm focuses on medical, industrial technology, life science, aerospace and defense sectors. It provides financing for management buyouts, recapitalizations of family businesses, corporate carve-outs, add-on acquisitions, industry consolidations and growth capital requirements. | Private Equity Investor | 2024-08-31 |
Former positions of David Montecalvo
| Companies | Position | End |
|---|---|---|
Sterlingtech, Inc.
 Sterlingtech, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices | Chief Executive Officer | 2023-10-31 |
| WEST PHARMACEUTICAL SERVICES, INC. | Chief Operating Officer | 2022-05-11 |
RBC Development LLC
 RBC Development LLC Packaged SoftwareTechnology Services Develops designs and manufacturing services for medical technology company | Chief Executive Officer | - |
Medtronic CardioVascular
 Medtronic CardioVascular Medical SpecialtiesHealth Technology Manufactures medical devices | Chief Operating Officer | - |
| MEDTRONIC PLC | Corporate Officer/Principal | - |
Training of David Montecalvo
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
77
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Urologix, Inc.
 Urologix, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets minimally invasive urological treatment products | Health Technology |
West Pharmaceutical Services, Inc.
 West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Thomas University (Florida)
 St. Thomas University (Florida) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic CardioVascular
Medtronic CardioVascular Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Vance Street Management LLC
Vance Street Management LLC Investment ManagersFinance Vance Street invests in middle market companies located in the United States or Canada with an enterprise values of USD 30 - 350 million and EBITDA of USD 3 - 30 million. The firm focuses on medical, industrial technology, life science, aerospace and defense sectors. It provides financing for management buyouts, recapitalizations of family businesses, corporate carve-outs, add-on acquisitions, industry consolidations and growth capital requirements. | Finance |
Olin Business School
Olin Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
 Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
Sterlingtech, Inc.
Sterlingtech, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
RBC Development LLC
RBC Development LLC Packaged SoftwareTechnology Services Develops designs and manufacturing services for medical technology company | Technology Services |
- Stock Market
- Insiders
- David Montecalvo
